Quantcast

Latest Embryonic stem cell Stories

2014-09-30 23:23:11

Provides North American researchers easy access to Biological Industries’ products Windsor, CT (PRWEB) September 30, 2014 Rainbow Scientific, Inc. (RSI), a North American distributor of scientific research products, recently opened an online store to add customer convenience in ordering its comprehensive cell culture product lines developed and manufactured by Biological Industries, Inc. Products available through its online store include Biological Industries’ Nutristem®...

2014-09-30 23:22:37

In a recent online interview by the Pharma IQ Division of the International Quality & Productivity Center (IQPC), James L. Sherley, M.D., Ph.D., the Director of the Adult Stem Cell Technology Center, LLC (ASCTC) discussed the state of technology for drug evaluations for stem cell toxicity. As an expert on the topic, Dr. Sherley emphasized that, currently, few technologies exist for screening-out drug candidates that will ultimately fail as medicines due to toxicity against stem cells...

2014-09-23 12:30:42

DALLAS, September 23, 2014 /PRNewswire/ -- RnRMarketResearch.com adds Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) - Regulatory Landscape, Pipeline Analysis & Global Forecasts to 2020 research report of 196 pages to its library. Complete report is available at...

2014-09-10 16:24:07

Media Company Mary Ann Liebert, Inc., Makes Foray from Scientific & Medical Journals to Consumer Arena with Launch of New Non-Fiction Work Inevitable Collision NEW ROCHELLE, New York, Sept. 10, 2014 /PRNewswire/ -- Mary Ann Liebert, Inc., leading publisher of over 80 science, technology, and medical publications, announced today the launch of first time hard cover title Inevitable Collision: The Inspiring Story that Brought Stem Cell Research to Conservative America, in an effort to...

2014-09-05 23:01:05

A study published in STEM CELLS on August 30, 2014, details a new, simple, and highly efficient way to convert cells taken from an adult’s skin into stem cells that have the potential to differentiate into white blood cells. Durham, NC (PRWEB) September 05, 2014 A study published in STEM CELLS on August 30, 2014, details a new, simple, and highly efficient way to convert cells taken from an adult’s skin into stem cells that have the potential to differentiate into white blood cells....

2014-09-04 16:27:31

MENLO PARK, Calif., Sept. 4, 2014 /PRNewswire/ -- Asterias Biotherapeutics, Inc. (OTCBB: ASTY) announced today that its Board of Directors has set Monday, September 15, 2014 as the record date (the "Record Date") for determining holders of its Series A common stock entitled to receive BioTime, Inc. common share purchase warrants in Asterias' previously announced warrant distribution. Asterias plans to distribute, on a pro rata basis, warrants to purchase 8,000,000 BioTime common...

2014-08-29 23:10:02

For more than a week, Boston’s Adult Stem Cell Technology Center, LLC has been declining offers from participants in the Amyotrophic Lateral Sclerosis (ALS) Ice Bucket Challenge who wish to make donations for research that does not use human embryonic stem cells or tissues derived from aborted fetuses. The company has informed those wishing to donate that its for-profit status prevents it from inviting or receiving charitable donations. Boston, MA (PRWEB) August 29, 2014 Due to a...

2014-08-29 08:24:07

DALLAS, August 29, 2014 /PRNewswire/ -- Launched June 2014, the "Stem Cell Research Products - Opportunities, Tools, and Technologies" market intelligence report supplies research supply companies with the real-time data necessary to make effective product development decisions, sell effectively to scientists, and take market share from the competition. Full-year 2013 analysis determines the size of the stem cell research products market to be $3.22 billion, and the stem cell...

2014-08-27 23:00:26

Upcoming New York Adult Stem Cell Lecture on Wednesday, September 3, 2014, at 2pm and 4pm at the City Limits Diner, at 135 Harvard Avenue, Stamford, CT 06902 New York, California (PRWEB) August 28, 2014 The Manhattan Regenerative Medicine Medical Group announces a series of free public seminars on the use of adult stem cells for various degenerative and inflammatory conditions. They will be provided by Dr. Thomas A. Gionis, Surgeon-in-Chief, and, Dr. Nia M. Smyrniotis, Medical Director....

2014-08-27 08:26:50

Dose Escalation Clinical Trial to Test Initial Safety and Activity of AST-OPC1 in Patient Population with the First Indication Targeted for Product Registration MENLO PARK, Calif., Aug. 27, 2014 /PRNewswire/ -- Asterias Biotherapeutics Inc. (OTCBB: ASTY) has received clearance from the U.S. Food and Drug Administration (FDA) to initiate a Phase 1/2a clinical trial of its product, AST-OPC1, in patients with complete cervical spinal cord injury. The approved trial follows the...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related